{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) 45% JV Reports IV Sapu003 Cuts GI Exposure to Everolimus by Up to 67-Fold

December 3, 2025Oncotelic Therapeutics (OTCQB: OTLC), 45% owner of the Sapu Nano joint venture, announced new pharmacokinetic and tissue-distribution data showing that Sapu003, its intravenous Deciparticle (TM) formulation of everolimus, dramatically reduces gastrointestinal drug accumulation compared with oral everolimus. Oral dosing drives extreme gut exposure—up to 2,448× plasma levels in the stomach—while IV Sapu003 limits GI tissue levels to just 36–48× plasma, representing reductions of up to 67-fold.


BioMedNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Details Encouraging LP-184 Phase 1a Results Showing Durable Disease Control in Advanced Solid Tumors

December 3, 2025Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company using artificial intelligence and genomics to transform oncology drug development, reported additional details and clinical insights from its completed Phase 1a dose-escalation study of LP-184 along with highlights from a recent webinar. The study in 63 heavily pre-treated patients with advanced solid tumors met all primary endpoints for safety and tolerability and established a clear recommended Phase 2 dose.


TechMediaBreaks – A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) Reaches Agreement With Major Central American Grocer to Deploy Smart Cart Platform

December 3, 2025A2Z Cust2Mate Solutions (NASDAQ: AZ), a global smart retail technology company, said it entered an agreement with a premium grocery retailer operating more than 50 stores in Central America to deploy the A2Z Cust2mate smart cart platform. Initial rollout is planned for early 2026 in two flagship locations, with the shared goal of expanding to a full chain-wide deployment following successful implementation.


TechMediaBreaks – Micropolis AI Robotics (NYSE: MCRP) Signs LOI With QSS Robotics to Expand Deployment in Saudi Arabia

December 3, 2025Micropolis AI Robotics (NYSE American: MCRP), a UAE-based developer of autonomous mobile robots and AI-driven security solutions, said it signed a non-binding Letter of Intent with QSS Robotics to establish a strategic collaboration for the distribution, localization, and deployment of Micropolis technologies across Saudi Arabia. The LOI outlines plans for commercial representation, joint engagement with government and private-sector customers, and integration and after-sales support under Micropolis supervision, building on agreements between the companies dating to 2022.


InvestorNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Featured in BioMedWire Editorial Highlighting HyBryte(TM) and Rare Disease Policy

December 3, 2025Soligenix (NASDAQ: SNGX) was featured in a BioMedWire editorial titled “Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now,” which examines the growing burden of rare diseases affecting more than 30 million Americans and the urgent need for new therapies. The article spotlights Soligenix’s late-stage development of HyBryte(TM) (synthetic hypericin) for cutaneous T-cell lymphoma, now in its final confirmatory study before worldwide marketing submissions, and places the Company’s efforts at the intersection of advancing treatment options and emerging national health policy initiatives.


BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Amends IND to Advance NRX-101 With TMS for Depression Treatment

December 3, 2025NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, said it amended its Investigational New Drug filing for NRX-101 to include use of the drug in combination with Transcranial Magnetic Stimulation for depression, including suicidal depression. The update follows evidence suggesting NRX-101 may significantly enhance TMS outcomes, with published studies showing more than two-fold improvements in symptom reduction and clinical response rates exceeding 80%.


InvestorNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Hits Record Black Friday Sales and Strongest November in Company History

December 3, 2025Newton Golf Company (NASDAQ: NWTG), a leader in physics-based golf shaft technology, said it achieved the highest single-day sales total in its history on Black Friday, driven by demand for its Fast Motion and Motion shaft families, and confirmed that November 2025 marks its strongest November on record. The Company reported its largest-ever 24-hour volume of direct-to-consumer orders, supported by rising tour adoption, greater brand visibility, strong repeat customer engagement, and a surge of first-time buyers.


BYD’s Battery Innovation Seeks to Reduce Dependence on Cobalt and Nickel

December 3, 2025BYD, a Chinese electric vehicle maker, is looking to leverage its Blade Battery as a way to reduce the quantity of minerals needed during the manufacture of batteries for EVs. Its battery technology is specifically designed to reduce the amount of nickel and cobalt required in vehicle electrification, and in this way, boost sustainability efforts as the world transitions to greener forms of transport.


EV Expertise Fuels Successes in Chinese-Made Flying Cars

December 3, 2025China’s battery-car mastery is propelling its flying vehicle manufacturers ahead of global rivals. Expertise developed through years of electric vehicle production and unmanned aircraft development is giving domestic companies a distinct edge in the nascent aerial mobility market.


Quantum Report Provides Insights on Public Awareness, Business Interest

December 3, 2025Quantum technology is moving from distant theory to something businesses and the public are starting to pay attention to. A new study called the Quantum Index Report 2025 shows how interest in quantum computing is growing, even though many people still do not fully understand it.